Diagnosis of gastric cancers with fluorescein-labeled monoclonal antibodies to carcinoembryonic antigen
- PMID: 2503669
- DOI: 10.1002/lsm.1900090415
Diagnosis of gastric cancers with fluorescein-labeled monoclonal antibodies to carcinoembryonic antigen
Abstract
Forty gastric adenocarcinomas in 30 resected stomachs were examined by an endoscopic immunofluorescent technique using fluorescein isothiocyanate (FITC)-labeled antibodies to carcinoembryonic antigen (CEA). Fluorescence images of the tumors were obtained with a newly developed endoscopic television system for detecting faint fluorescence. Computer-assisted processing was used to enhance the detection and localization of the tumors visualized by the immunofluorescent technique. Twenty seven (90%) of 30 tumors showed positive fluorescence after treatment with FITC-labeled antibodies for 60 minutes, whereas only two (40%) of five cancers could be detected by the immunofluorescent technique after treatment with antibodies for less than 60 minutes. There was no significant relationship between positive fluorescence and the gross and histological types or the stages of the tumors. In contrast, no positive fluorescence could be demonstrated in cases of benign gastric lesions or after pretreatment with FITC-labeled alpha-fetoprotein. This study therefore suggests that the immunofluorescent technique using FITC-labeled anti-CEA antibodies can be useful in detecting the early stages of gastric cancer.
Similar articles
-
Detection of human gastric cancer in resected specimens using a novel infrared fluorescent anti-human carcinoembryonic antigen antibody with an infrared fluorescence endoscope in vitro.Endoscopy. 2001 Oct;33(10):849-53. doi: 10.1055/s-2001-17328. Endoscopy. 2001. PMID: 11571680
-
Immunohistochemical characterization of a new anti-carcinoembryonic antigen monoclonal antibody.Anticancer Res. 1991 Jan-Feb;11(1):1-12. Anticancer Res. 1991. PMID: 1902071
-
Differential expression of carcinoembryonic antigen in early gastric adenocarcinomas versus benign gastric lesions defined by monoclonal antibodies reactive with restricted antigen epitopes.Cancer Res. 1987 Jul 1;47(13):3565-71. Cancer Res. 1987. PMID: 3555774
-
Principle and clinical usefulness of the infrared fluorescence endoscopy.J Med Invest. 2006 Feb;53(1-2):1-8. doi: 10.2152/jmi.53.1. J Med Invest. 2006. PMID: 16537990 Review.
-
The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review.Biomolecules. 2021 Dec 2;11(12):1819. doi: 10.3390/biom11121819. Biomolecules. 2021. PMID: 34944463 Free PMC article. Review.
Cited by
-
Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen.Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):7973-7. doi: 10.1073/pnas.89.17.7973. Proc Natl Acad Sci U S A. 1992. PMID: 1518823 Free PMC article. Clinical Trial.
-
Imaging in the era of molecular oncology.Nature. 2008 Apr 3;452(7187):580-9. doi: 10.1038/nature06917. Nature. 2008. PMID: 18385732 Free PMC article. Review.
-
Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo.Cancer Res. 2001 Jun 1;61(11):4490-6. Cancer Res. 2001. PMID: 11389080 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
